Clinical Trial Update: A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia

View source ↗

Summary

This entry notes the termination of a Corcept Therapeutics-sponsored clinical trial evaluating recurrent or persistent Cushing's syndrome in patients with hyper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Syndrome

Drugs mentioned

• Korlym (mifepristone)

Snippet

Sponsor: Corcept Therapeutics | Conditions: Cushing's Syndrome | Status: TERMINATED